ATE272071T1 - Verwendung eines extrazellulären hämoglobins mit höherem molekulargewicht als blutersatz - Google Patents

Verwendung eines extrazellulären hämoglobins mit höherem molekulargewicht als blutersatz

Info

Publication number
ATE272071T1
ATE272071T1 AT01936553T AT01936553T ATE272071T1 AT E272071 T1 ATE272071 T1 AT E272071T1 AT 01936553 T AT01936553 T AT 01936553T AT 01936553 T AT01936553 T AT 01936553T AT E272071 T1 ATE272071 T1 AT E272071T1
Authority
AT
Austria
Prior art keywords
blood substitute
molecular weight
approximately
higher molecular
extracellular hemoglobin
Prior art date
Application number
AT01936553T
Other languages
English (en)
Inventor
Franck Zal
Andre Toulmond
Francois Lallier
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE272071T1 publication Critical patent/ATE272071T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01936553T 2000-05-31 2001-05-17 Verwendung eines extrazellulären hämoglobins mit höherem molekulargewicht als blutersatz ATE272071T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0007031A FR2809624B1 (fr) 2000-05-31 2000-05-31 Utilisation comme substitut sanguin d'une hemoglobine extracellulaire de poids moleculaire eleve
PCT/FR2001/001505 WO2001092320A2 (fr) 2000-05-31 2001-05-17 Utilisation comme substitut sanguin d'une hemoglobine extracellulaire de poids moleculaire eleve

Publications (1)

Publication Number Publication Date
ATE272071T1 true ATE272071T1 (de) 2004-08-15

Family

ID=8850865

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01936553T ATE272071T1 (de) 2000-05-31 2001-05-17 Verwendung eines extrazellulären hämoglobins mit höherem molekulargewicht als blutersatz

Country Status (9)

Country Link
US (2) US20030181358A1 (de)
EP (1) EP1284994B1 (de)
JP (1) JP5001500B2 (de)
AT (1) ATE272071T1 (de)
AU (1) AU6243601A (de)
DE (1) DE60104542T2 (de)
DK (1) DK1284994T3 (de)
FR (1) FR2809624B1 (de)
WO (1) WO2001092320A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2860796B1 (fr) * 2003-10-14 2006-02-10 Centre Nat Rech Scient Procede de dissociation de la molecule d'hemoglobine extracellulaire d'arenicola marina, chaines proteiques constituant ladite molecule et sequences nucleotidiques codant pour lesdites chaines proteiques
CA2637895C (en) * 2006-01-24 2014-03-18 Centre National De La Recherche Scientifique (Cnrs) Use of a high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and/or preventing diseases by inhibition of calcium
FR2919785B1 (fr) * 2007-08-09 2017-10-20 Hemarina Sa Utilisation d'une globine, d'un protomere de globine ou d'une hemoglobine extracellulaire pour la preservation d'organes, de tissus, ou de cellules d'organes ou de tissus, ou de culture de cellules
NL1035741C2 (en) * 2008-07-23 2010-01-26 Albertus Ide Marie Meijering Extracellular hemoglobin blood substitute derived from ragworm species and the use.
US10119110B2 (en) * 2009-04-23 2018-11-06 Hemarina Bioreactor using oxygen-carrying molecules
ES2625893T3 (es) 2009-05-01 2017-07-20 Bimini Technologies Llc Sistemas, procedimientos y composiciones para optimizar injertos enriquecidos con tejido y células
DK2427483T3 (en) 2009-05-07 2015-05-04 Hemarina Novel hemoglobin and uses thereof
US8273857B2 (en) * 2009-09-22 2012-09-25 Jen-Chang Hsia Compositions and methods of use of neurovascular protective multifunctional polynitroxylated pegylated carboxy hemoglobins for transfusion and critical care medicine
FR2991327B1 (fr) 2012-06-05 2018-04-13 Hemarina Procede de lyophilisation d'hemoglobine d'annelides
FR3002146B1 (fr) * 2013-02-15 2016-03-04 Hemarina Utilisation d'hemoglobine d'annelides pour traiter les cancers
FR3005663B1 (fr) * 2013-05-16 2016-02-26 Hemarina Lyophilisat de ver marin et ses utilisations
EP3092213B1 (de) 2013-12-27 2019-10-23 Virginia Commonwealth University Allosterische hämoglobin-modifikatoren mit stickoxidfreisetzendem teil
CL2018002378A1 (es) * 2018-08-20 2018-10-12 Univ Austral De Chile Medicamento útil como sustituto sanguineo para tratar, a la vez, la anemia aguda por pedida de sangre y la infección bacteriana en mamíferos
WO2022040820A1 (es) * 2020-08-28 2022-03-03 Universidad Austral De Chile Suplemento alimenticio para prevenir la anemia y con efecto orexígeno y vigorizante en animales

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599907A (en) * 1989-05-10 1997-02-04 Somatogen, Inc. Production and use of multimeric hemoglobins
US5405742A (en) * 1993-07-16 1995-04-11 Cyromedical Sciences, Inc. Solutions for tissue preservation and bloodless surgery and methods using same
IS4198A (is) * 1993-08-13 1995-02-14 Somatogen, Inc Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða
US5929031A (en) * 1995-05-02 1999-07-27 Baxter Biotech Technology Sarl Storage stable hemoglobin solutions

Also Published As

Publication number Publication date
FR2809624A1 (fr) 2001-12-07
EP1284994A2 (de) 2003-02-26
AU6243601A (en) 2001-12-11
WO2001092320A3 (fr) 2002-04-04
EP1284994B1 (de) 2004-07-28
DK1284994T3 (da) 2004-11-29
US20080305178A1 (en) 2008-12-11
US20030181358A1 (en) 2003-09-25
FR2809624B1 (fr) 2002-08-02
JP5001500B2 (ja) 2012-08-15
WO2001092320A2 (fr) 2001-12-06
DE60104542T2 (de) 2005-09-01
JP2004501118A (ja) 2004-01-15
DE60104542D1 (de) 2004-09-02

Similar Documents

Publication Publication Date Title
ATE272071T1 (de) Verwendung eines extrazellulären hämoglobins mit höherem molekulargewicht als blutersatz
TW200631604A (en) Ophthalmic compositions comprising polyether substituted polymers
DE50207744D1 (de) Pfropfpolymerisate mit stickstoffheterocyclen enthaltenden seitenketten
ATE293799T1 (de) Kontaktlinsenmaterial auf basis von polysiloxanseitenketten enthaltenden makromonomere
ES2120042T3 (es) Polimero de varilla rigida a base de piridobisimidazol.
ATE545660T1 (de) Verfahren zur herstellung von niedermolekularem kationischem polygalactomannan mit verringertem geruch
ATE385765T1 (de) Kosmetische zusammensetzung mit einem polymergemisch
DK0762888T3 (da) Copolymer-1 forbedringer i præparater af copolymerer
DK1196444T3 (da) Exendin-4-konjugater og deres medicinske anvendelighed
MX9207284A (es) Copolimeros para elaborar aparatos biomedicos.
ATE350385T1 (de) Neue aryl fructose-1,6-bisphosphatase inhibitoren
WO2004060273A3 (en) Skin care composition containing an anionic polymer
DE60101283D1 (de) "Living radical" Polymerisation
DE59601616D1 (de) Polymerisate, deren herstellung und verwendung
ATE320814T1 (de) Verwendung von zinkhyaluronat gegen magengeschwür
DE69112420D1 (de) Makromolekulare monomere aus lebenden polymeren.
BR0212895A (pt) Métodos e composições de novos compostos de triazina
FR2889062B1 (fr) Composition cosmetique comprenant un copolymere ampholyte
GB2375767B (en) Photo-polymers and use thereof
DE60313786D1 (de) Poly(ethylen glykol)-konjugate von insulinähnlichem wachstumfaktor bindenden protein-4
DK0663208T3 (da) Kombinationer af polymerer til anvendelse i kunstige tårepræparater
AU4178900A (en) Dip-molded medical devices from cis-1,4-polyisoprene
DE69914869D1 (de) Hochtransparente Polymerzusammensetzung
ATE278719T1 (de) Teilverzweigte polymere
DE69807204D1 (de) Kosmetische zusammensetzung auf der basis von assoziativen polyurethanen und anionischen polymeren mit fettketten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties